Thompson Rahsaan's Form 4 filing
Zevra Therapeutics, Inc. (ZVRA) · filed Feb 2, 2026
- Accession no.
- 0001788524-26-000002
- Filed
- Feb 2, 2026
- Trade date
- Jan 29-30, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $36.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson RahsaanCIK 0001788524 | Officer (Chief Legal & Compliance), Other: Secretary |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | AGrant or awardAcquired | +37,500 | $0.00 | $0 | 37,500 | Direct | |
| Jan 29, 2026 | Common Stock | AGrant or awardAcquired | +75,000 | $0.00 | $0 | 75,000 | Direct | |
| Jan 30, 2026 | Common Stock | MOption exerciseDisposed | −11,333 | $0.00 | $0 | 22,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $8.58 to $9.04. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.